Kelly Financial Services’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-60
| Closed | -$1.47K | – | 520 |
|
|
2024
Q2 | $1.47K | Hold |
60
| – | – | ﹤0.01% | 619 |
|
|
2024
Q1 | $1.28K | Hold |
60
| – | – | ﹤0.01% | 643 |
|
|
2023
Q4 | $1.15K | Hold |
60
| – | – | ﹤0.01% | 642 |
|
|
2023
Q3 | $962 | Hold |
60
| – | – | ﹤0.01% | 623 |
|
|
2023
Q2 | $1.39K | Hold |
60
| – | – | ﹤0.01% | 574 |
|
|
2023
Q1 | $1.39K | Hold |
60
| – | – | ﹤0.01% | 558 |
|
|
2022
Q4 | $871 | Hold |
60
| – | – | ﹤0.01% | 577 |
|
|
2022
Q3 | $1.15K | Hold |
60
| – | – | ﹤0.01% | 560 |
|
|
2022
Q2 | $1.09K | Hold |
60
| – | – | ﹤0.01% | 551 |
|
|
2022
Q1 | $1.51K | Hold |
60
| – | – | ﹤0.01% | 548 |
|
|
2021
Q4 | $1.66K | Hold |
60
| – | – | ﹤0.01% | 559 |
|
|
2021
Q3 | $1.94K | Sell |
60
-1,775
| -97% | -$57.3K | ﹤0.01% | 516 |
|
|
2021
Q2 | $60K | Buy |
1,835
+1,775
| +2,958% | +$58K | ﹤0.01% | 435 |
|
|
2021
Q1 | $1.83K | Hold |
60
| – | – | ﹤0.01% | 509 |
|
|
2020
Q4 | $1.19K | Hold |
60
| – | – | ﹤0.01% | 503 |
|
|
2020
Q3 | $782 | Hold |
60
| – | – | ﹤0.01% | 503 |
|
|
2020
Q2 | $680 | Hold |
60
| – | – | ﹤0.01% | 522 |
|
|
2020
Q1 | $859 | Hold |
60
| – | – | ﹤0.01% | 477 |
|
|
2019
Q4 | $1.63K | Hold |
60
| – | – | ﹤0.01% | 432 |
|
|
2019
Q3 | $1.72K | Hold |
60
| – | – | ﹤0.01% | 413 |
|
|
2019
Q2 | $1.67K | Hold |
60
| – | – | ﹤0.01% | 391 |
|
|
2019
Q1 | $1.99K | Buy |
+60
| New | +$1.99K | ﹤0.01% | 372 |
|